About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 63457 record(s)
Req # A-2021-001541
Adverse Drug Reaction (ADR) for ALLERGENIC EXTRACT - ALBUMIN SALINE WITH PHENOL. Report number: 000959909.Organization: Health Canada
June 2022
Req # A-2021-001628
Adverse Drug Reaction (ADR) for BUDESONIDE. Report number: E2B_04323333.Organization: Health Canada
June 2022
Req # A-2021-001675
Adverse Drug Reaction (ADR) for IPRATROPIUM BROMIDE. Report number: E2B_04133439.Organization: Health Canada
June 2022
Req # A-2021-001723
Adverse Drug Reactions (ADRs) for METFORMIN HYDROCHLORIDE. Report numbers: E2B_04458023, E2B_04122589, E2B_04181591, 000956566, 000961233, 000962239, 000955149, 000961005, E2B_04464691, 000969222, 000955170.Organization: Health Canada
June 2022
Req # A-2021-001728
Adverse Drug Reactions (ADRs) for BISACODYL, CLOPIDOGREL BISULFATE. Report numbers: E2B_04404907, E2B_02446830, E2B_04507202, E2B_04417983, E2B_04425447, E2B_04430322, E2B_04509601, E2B_04302220, 000963962, E2B_04159458, E2B_04265240, 000957103.Organization: Health Canada
June 2022
Req # A-2021-001855
Adverse Drug Reactions (ADRs) for Morphine. Report numbers: E2B_04656605, E2B_03684409, E2B_04710450. ADR for Hydromorphone. Report number: E2B_04706954. ADRs for Midazolam. Report numbers: E2B_04639930, E2B_04646568.Organization: Health Canada
June 2022
Req # A-2021-001892
Adverse Drug Reactions (ADRs). Report numbers: 000970401, E2B_04594121, E2B_04647826, E2B_04722813, E2B_04726650, 000966735, E2B_04645718, E2B_04652079, E2B_04683448, E2B_04706248, E2B_04728917, E2B_04729787, 000969614, E2B_04675165, E2B_04681594, E2B_02447703, E2B_04578918, E2B_04656755, E2B_04674005, E2B_04678301.Organization: Health Canada
June 2022
Req # A-2021-001894
Adverse Drug Reactions (ADRs). Report numbers: 000970401, E2B_04594121, E2B_04647826, E2B_04722813, E2B_04726650, 000966735, E2B_04645718, E2B_04652079, E2B_04683448, E2B_04706248, E2B_04728917, E2B_04729787, 000969614, E2B_04675165, E2B_04681594, E2B_02447703, E2B_04578918, E2B_04656755, E2B_04674005, E2B_04678301.Organization: Health Canada
June 2022
Req # A-2021-001905
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-121367-21.Organization: Health Canada
June 2022
Req # A-2021-001912
Adverse Drug Reactions (ADRs). Report numbers: 000968830, E2B_04373994, E2B_04501798, E2B_04502236, E2B_04790525, E2B_04799814, E2B_04589242, 000958995, 000961642, 000966574.Organization: Health Canada
June 2022